Lymphocyte recognition of human parvovirus B19 non-structural (NS1) protein: Associations with occurrence of acute and chronic arthropathy?

Journal of Medical Microbiology

Volumn 50, Issue 7, 2001, Pages 627-635

  Mitchell, L A J ^a   Leong, R ^a   Rosenke, K A ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ADULT; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTHROPATHY; ARTICLE; DNA SEQUENCE; FEMALE; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS RECOMBINANT;

EID: 0034948979     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-50-7-627     Document Type: Article

References (32)

1. Human parvovirus B19 epidemiology and clinical manifestations
2. Clinical manifestations of human parvovirus B19 in adults
3. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum
4. Association between human parvovirus B19 infection and arthritis
5. Human parvovirus B19 as a causative agent for rheumatoid arthritis
6. Human parvovirus B19-associated arthritis in children
7. Prevalence of antihuman parvovirus B19 antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis
8. Influence of previous exposure to human parvovirus B19 infection in explaining susceptibility to rheumatoid arthritis: An analysis of disease discordant twin pairs
9. Does parvovirus B19 have a role in rheumatoid arthritis?
10. A study of the role of parvovirus B19 in rheumatoid arthritis
11. Characterization of capsid and noncapsid proteins of B19 parvovirus propogated in human erythroid bone marrow cell cultures
12. Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: Evidence for B19 persistence
13. Persistent infection of human parvovirus B19 in a normal subject
14. Persistence of parvovirus B19 in synovial fluid and bone marrow
15. Detection of parvovirus B19 DNA in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis
16. Parvovirus B19 clearance from peripheral blood after acute infection
17. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy
18. B19 parvovirus: Biochemical and molecular features
19. A block in full-length transcript maturation in cells non-permissive for B19 parvovirus
20. Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: Implications for pathogenesis
21. Antibodies to parvovirus B19 NS1 protein in infected individuals
22. Immune response to B19 infection
23. Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection
24. Lymphoproliferative responses after infection with human parvovirus B19
25. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis
26. Identification of immunoreactive regions of rubella E1 and E2 envelope proteins by using synthetic peptides
27. Parvovirus B19 and erosive polyarthritis
28. Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells
29. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression
30. Non-permissiveness of synovial membrane cells to human parvovirus B19 in vitro
31. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen
32. A genome-linked copy of the NS-1 polypeptide is located on the outside of infectious parvovirus particles